AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 SEP 26 - (NewsRx.com & NewsRx.net) -- Computerized Thermal Imaging (CIO) announced that Massachusetts General Hospital (MGH) will conduct a clinical study to help evaluate the company's breast imaging system.
The system utilizes noninvasive thermal imaging technology that could help physicians differentiate between a patient's benign or malignant breast lesions. The study will begin in the fall and will be led by Dr. Kevin Hughes, MGH surgical oncologist, in association with Dr. Daniel Kopans, director of breast imaging at MGH and professor of radiology at Harvard Medical School.
The initiation of this clinical study follows the announcement of two additional milestones for Computerized Thermal Imaging's (CTI) breast imaging system. The company has received notification from the U.S. Food and Drug Administration that a Radiological Devices Panel has been scheduled in October to review, discuss, and make recommendations regarding CTI's premarket approval (PMA) application for its breast imaging system.
In addition, the peer-reviewed medical publication American Journal of Roentgenology has accepted a clinical paper about clinical trial results of the breast imaging system for its January 2003 issue.
"We believe that MGH has a responsibility to evaluate new technologies that might benefit our patients. The breast imaging division ...
Source: HighBeam Research, Massachusetts General to begin computerized thermal breast imaging...